Brand Name for Dapagliflozin
The brand name for dapagliflozin is Farxiga in the United States and Forxiga in the European Union. 1, 2, 3, 4
Regional Naming
- United States: Farxiga® (manufactured by AstraZeneca) 1, 2, 3
- European Union: Forxiga® (manufactured by AstraZeneca) 1, 4, 5
Both brand names refer to the same medication—dapagliflozin, an SGLT2 inhibitor—with identical formulations and indications. The naming difference is purely regional marketing convention by the manufacturer.
Clinical Context
Dapagliflozin is available as oral film-coated tablets in 5 mg and 10 mg strengths 2. The drug has multiple FDA-approved indications beyond its original diabetes indication, including heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), and chronic kidney disease 2, 3, 4.